Biogen (BIIB) Dividends Paid - Common (2009 - 2020)
Biogen (BIIB) recorded quarterly Dividends Paid - Common of $100000.0 in Q4 2020, down 99.86% quarter-over-quarter from $70.9 million in Q3 2020, and down 97.67% on a YoY basis from $4.3 million in Q1 2020.
Biogen (BIIB) Dividends Paid - Common (2009 - 2020) Analysis & Trends
Biogen's Dividends Paid - Common history runs 8 years deep, the most recent figure standing at $100000.0 for Q4 2020.
- In Q4 2020, Dividends Paid - Common fell 97.67% year-over-year to $100000.0; the TTM figure through Sep 2021 stood at $75.3 million (up 96.61% YoY), while the FY2020 annual figure was $71.0 million, changed N/A from the prior year.
- Dividends Paid - Common was $100000.0 for Q4 2020 at Biogen, down from $70.9 million in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $302.7 million in Q1 2017 to a low of -$302.7 million in Q3 2017.
- Historically, Dividends Paid - Common has averaged $24.5 million across 4 years, with a median of $4.3 million in 2019.
- The sharpest annual moves came in 2018 and 2019: Dividends Paid - Common tumbled 127.52% in 2018, then jumped 111.65% in 2019.
- A 4-year view of Dividends Paid - Common shows it stood at $134.1 million in 2017, then tumbled by 127.52% to -$36.9 million in 2018, then jumped by 111.65% to $4.3 million in 2019, then plunged by 97.67% to $100000.0 in 2020.
- The last three Dividends Paid - Common figures came in at $100000.0 (Q4 2020), $70.9 million (Q3 2020), and $4.3 million (Q4 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -866.88 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 1.55 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 3.13 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 3.09 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 1.28 Bn |
| 10 | Biogen | 28.75 Bn | 24.47 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 100,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Sep 30, 2020 | 70.90 Mn |
| Sep 30, 2020 | 70.90 Mn |
| Dec 31, 2019 | 4.30 Mn |
| Dec 31, 2019 | 4.30 Mn |
| Dec 31, 2018 | -36.90 Mn |
| Dec 31, 2018 | -36.90 Mn |
| Sep 30, 2018 | -2.00 Mn |
| Sep 30, 2018 | -2.00 Mn |
| Jun 30, 2018 | 50.00 Mn |
| Jun 30, 2018 | 50.00 Mn |
| Dec 31, 2017 | 134.10 Mn |
| Dec 31, 2017 | 134.10 Mn |
| Sep 30, 2017 | -302.70 Mn |
| Sep 30, 2017 | -302.70 Mn |
| Mar 31, 2017 | 302.70 Mn |
| Mar 31, 2017 | 302.70 Mn |
| Sep 30, 2015 | 60.00 Mn |
| Sep 30, 2015 | 60.00 Mn |